These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28755512)

  • 1. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paper Spray Ionization Coupled to High Resolution Tandem Mass Spectrometry for Comprehensive Urine Drug Testing in Comparison to Liquid Chromatography-Coupled Techniques after Urine Precipitation or Dried Urine Spot Workup.
    Michely JA; Meyer MR; Maurer HH
    Anal Chem; 2017 Nov; 89(21):11779-11786. PubMed ID: 29022692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried urine spots - A novel sampling technique for comprehensive LC-MS
    Michely JA; Meyer MR; Maurer HH
    Anal Chim Acta; 2017 Aug; 982():112-121. PubMed ID: 28734350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    Anal Chim Acta; 2015 Sep; 891():221-33. PubMed ID: 26388381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (±)-3,4-methylenedioxyethylamphetamine, phencyclidine, and (±)-11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol.
    Stout PR; Bynum ND; Lewallen CM; Mitchell JM; Baylor MR; Ropero-Miller JD
    J Anal Toxicol; 2010 Oct; 34(8):430-43. PubMed ID: 21819787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
    Welter J; Meyer MR; Kavanagh P; Maurer HH
    Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of urine and hair testing for drugs of abuse in the control of abstinence in driver's license re-granting.
    Dufaux B; Agius R; Nadulski T; Kahl HG
    Drug Test Anal; 2012 Jun; 4(6):415-9. PubMed ID: 22447399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated analysis of dried urine spot (DUS) samples for toxicology screening.
    Pablo A; Breaud AR; Clarke W
    Clin Biochem; 2020 Jan; 75():70-77. PubMed ID: 31707014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-HR-MS/MS standard urine screening approach: Pros and cons of automated on-line extraction by turbulent flow chromatography versus dilute-and-shoot and comparison with established urine precipitation.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():138-149. PubMed ID: 27381570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.